Cancer BiologyThe FASEB JournalPeer-reviewed
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.
Rajendra Kumar, Janet Mendonca, Abhishek Shetty…·Sushant K. Kachhap
This study shows CRM1 regulates androgen receptor stability and DNA repair in prostate cancer, suggesting combination therapy with CRM1 and DNA repair inhibitors could be effective.
2 citations